Research Options: Select below IPO Calendar	Week of Expected Pricing Pending Company Name Novacardia Inc Proposed Ticker NCAR CUSIP N/A Business Description A clinical-stage pharmaceutical company focused on developing drugs to treat major cardiovascular diseases that are underserved by existing therapies. Lead Underwriter JPMorgan, Credit Suisse Co-Managers Pacific Growth Equities LLC, First Albany Capital Initial Shares N/A Revised Initial Shares N/A Initial Price N/A Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.